Parathormone enhances eryptosis in patients with end stage renal disease treated by hemodialysis.
Aya HefnyAbeer A FikryMahmoud H ZahranAli Moustafa ShendiPublished in: Hemodialysis international. International Symposium on Home Hemodialysis (2021)
Patients with CKD5d express high rates of eryptosis. PTH excess in those patients may result in further eryptosis enhancement, and this represents a potential pathogenic mechanism linking hyperparathyroidism with the anemia of CKD.